Last reviewed · How we verify
placebo of folic acid
placebo of folic acid is a Vitamin B9 Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 3 development for Prevention of neural tube defects in pregnant women.
Folic acid is a synthetic form of vitamin B9 that plays a crucial role in various bodily functions, including DNA synthesis and repair.
Folic acid is a synthetic form of vitamin B9 that plays a crucial role in various bodily functions, including DNA synthesis and repair. Used for Prevention of neural tube defects in pregnant women.
At a glance
| Generic name | placebo of folic acid |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Drug class | Vitamin B9 |
| Modality | Small molecule |
| Therapeutic area | Nutritional supplements |
| Phase | Phase 3 |
Mechanism of action
Folic acid is essential for the production of red blood cells and the maintenance of healthy homocysteine levels in the blood. It also helps in the repair of damaged DNA and the synthesis of new DNA during cell division.
Approved indications
- Prevention of neural tube defects in pregnant women
Common side effects
- Gastrointestinal upset
Key clinical trials
- A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer (PHASE3)
- Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment (NA)
- A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer (PHASE3)
- A Study Evaluating Quality of Life Parameters Following Use of Emergen-C (PHASE4)
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) (PHASE3)
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension (PHASE3)
- A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV. (NA)
- Validation of a Novel Functional Food Designed to Meet the Nutritional Needs of People Living With Parkinson's Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo of folic acid CI brief — competitive landscape report
- placebo of folic acid updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about placebo of folic acid
What is placebo of folic acid?
How does placebo of folic acid work?
What is placebo of folic acid used for?
Who makes placebo of folic acid?
What drug class is placebo of folic acid in?
What development phase is placebo of folic acid in?
What are the side effects of placebo of folic acid?
Related
- Drug class: All Vitamin B9 drugs
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
- Therapeutic area: All drugs in Nutritional supplements
- Indication: Drugs for Prevention of neural tube defects in pregnant women
- Compare: placebo of folic acid vs similar drugs
- Pricing: placebo of folic acid cost, discount & access